TRUMP’S RETURN COULD PROMPT TOUGHER U.S. ACTIONS ON FENTANYL

Donald Trump’s return to power could lead to a more aggressive U.S. stance on addressing the fentanyl crisis, with a focus on China. Advisors to Trump’s transition team advocate for stronger actions against Beijing, including tariffs and sanctions on Chinese financial institutions linked to the fentanyl trade. Trump has already proposed additional tariffs on Chinese goods and criticized both China and Mexico for not doing enough to prevent the flow of fentanyl into the U.S. China is a major source of precursor chemicals used by Mexican cartels to manufacture fentanyl. The Biden administration has taken a more diplomatic approach, but some U.S. officials argue that tougher actions, including sanctions on Chinese banks, are necessary. China has resisted U.S. demands for tighter control of its chemical exports, while some believe Beijing is using fentanyl to destabilize the U.S. Trump’s strategy may focus on sanctions and more direct confrontations with both China and Mexico to address the crisis. (Reuters)

---

STUDY HIGHLIGHTS VACCINE EFFECTIVENESS AGAINST HOUSEHOLD FLU INFECTIONS

A study of 700 individuals who tested positive for influenza found that their risk of infecting household contacts was 18.8%, with flu vaccines showing an estimated effectiveness of 21.0% in preventing secondary infections. Conducted by Vanderbilt University, the study analyzed nasal swabs and symptom diaries from participants and their 1,581 household members during the 2017-2020 flu seasons. Researchers found that unvaccinated household members were at high risk of infection, particularly children under 5, who had a secondary infection rate of 20.3% for influenza A. Vaccine effectiveness was higher for influenza B (56.4%), especially in children and adults aged 5-49 years. The study highlights the high transmission risk in households and suggests complementary preventive measures such as isolation, improved ventilation, hand hygiene, and antiviral prophylaxis. The findings were published in JAMA Network Open, emphasizing the importance of vaccines in reducing secondary infections, particularly for those at higher risk of severe illness. (CIDRAP)

---

---

CASSAVA SCIENCES’ SIMUFILAM FAILS IN PHASE 3 ALZHEIMER’S TRIAL

Cassava Sciences’ phase 3 Alzheimer’s disease trial of simufilam has failed to meet its co-primary endpoints, missing both secondary and exploratory biomarker endpoints. The trial, involving over 800 people with mild-to-moderate Alzheimer’s, compared simufilam to a placebo over 52 weeks. Results showed no significant improvements in cognitive or functional impairment, with scores on the ADAS-COG12 and ADCS-ADL scales being similar in both the simufilam and placebo groups. The p-values were 0.43 and 0.40, respectively, indicating statistical insignificance. Cassava has decided to stop a second phase 3 trial and an open-label extension. CEO Rick Barry noted the less pronounced loss of cognition in the placebo group compared to other studies but did not use this to argue for simufilam’s potential. The company will review the data and consider next steps. Despite prior controversies surrounding the drug’s development, the stock plummeted 85% in premarket trading following the announcement. (Fierce Biotech)

---

HUMMINGBIRDS INSPIRE ROBOTIC DRONES FOR MODERN WARFARE DEVELOPMENT

Hummingbirds, known for their exceptional aerial abilities, are inspiring the development of robotic drones for use in modern warfare. Their remarkable flight skills, including hovering, rapid direction changes, and even flying upside down, have caught the attention of researchers working on bio-inspired technology. Hummingbirds are unmatched in maneuverability, with wings beating 50 times per second and hearts beating 1,200 times a minute. Researchers, funded by defense agencies like the U.S. Office of Naval Research, are studying these birds to design better robotic flying machines. Despite efforts like the NanoHummingbird, current robots still struggle to match the bird’s agility and speed. Key challenges include replicating the wing and tail shape-shifting, sensory feedback systems, and the bird’s adaptability to wind. While progress continues, experts predict that achieving a functional robotic hummingbird capable of such complex maneuvers will take years, possibly decades, due to the technical and biological complexities involved. (New York Times)

---

---

NVIDIA’S FUGATTO PUSHES LIMITS OF GENERATIVE AI IN AUDIO CREATION

Nvidia’s “Fugatto” model pushes the boundaries of generative AI by synthesizing not only music and speech but also entirely new sounds, including combinations never heard before. Using innovative training methods, Fugatto can transform any mix of music, voices, and sounds with remarkable flexibility. It can generate sounds like a saxophone barking, or a choir of ambulance sirens, showcasing its versatility. The model is trained on a massive dataset of 20 million samples representing 50,000 hours of audio, enabling it to recognize and manipulate complex audio traits like emotion, gender, and speech quality. Its “ComposableART” system can mix disparate traits, producing unique sounds, such as a violin that sounds like a laughing baby. Fugatto treats audio traits as tunable continuums, allowing users to modify characteristics like accent or emotion. While still evolving, Fugatto offers potential applications in music creation, video game soundtracks, and advertising, emphasizing its role as a tool for audio artists rather than a replacement for their creativity. (Ars Technica)

---

RESEARCHERS CREATE DIGITAL AVATAR OF RICHARD III WITH YORKSHIRE ACCENT

Researchers have created a digital avatar of Richard III, England’s 15th-century monarch, allowing him to “speak” in a Yorkshire accent. The project, “A Voice for King Richard III,” began after the king’s remains were discovered in 2012 beneath a parking lot in Leicester. Vocal coach Yvonne Morley-Chisholm, intrigued by the discovery, reached out to experts to explore Richard’s voice, sparking a collaborative effort involving specialists in fields like dentistry, craniofacial reconstruction, and linguistics. The team worked to recreate his features and accent, with linguist David Crystal researching 15th-century pronunciation. Though the avatar speaks with the voice of actor Thomas Dennis, it aims to reflect how Richard may have sounded in life. Unlike the villainous portrayal in Shakespeare’s play, this version of Richard comes across as soft-spoken and more relatable. The exhibit at York Theatre Royal encourages visitors to reconsider whether Richard was a ruthless monarch or a misunderstood ruler. (Smithsonian Magazine)

---

A new study published in the Proceedings of the National Academy of Science reveals that Indigenous peoples in what is now British Columbia have been cultivating beaked hazelnuts for at least 7,000 years, challenging the belief that pre-colonial Indigenous communities were solely hunter-gatherers. The research indicates that the Gitxsan, Tsimshian, and Nisga’a peoples actively transplanted and cultivated hazelnuts, as evidenced by genetic analysis showing five distinct subgroups of hazelnuts. Linguistic evidence also suggests a trade in hazelnuts, as the word for the nut in Gitxsan and Nisga’a languages was borrowed from the Coast Salish. The study highlights the significant role Indigenous peoples played in shaping ecosystems, contradicting the assumption that the region was untouched by human influence. The findings also support oral histories of an ancient city near the Skeena and Bulkley rivers, offering modern scientific backing to Indigenous knowledge and emphasizing the importance of stewardship over traditional lands. (CBC)

Thanks for reading. Let’s be careful out there.

WORDS: The Biology Guy.

---

---